Healthtech funding in Q4 2012

European Healthtech startup funding raised during Q4 2012.

In Q4 2012, 25 European Healthtech companies closed 25 funding rounds and raised €126M in equity funding (excluding debt and grants), down 25.9% versus Q4 2011. Switzerland led by capital raised, and Amadeus Capital Partners was the most active investor. Data as of 6 Nov 2026.

Equity funding

€126M

-25.9% vs Q4 2011 · excl. debt & grants

Funding rounds

+66.7% vs Q4 2011

Companies

Top country

Switzerland

Rank among sectors

10.3% of sector funding

Top-10 round share

91.9%

of disclosed capital

Funding by month

€ raised vs rounds, by month

Data table

	Funding	Rounds
Oct	€16M	5
Nov	€60M	9
Dec	€58M	11

Top countries

by € raised

Data table

	Healthtech — top countries by capital, Q4 2012
Switzerland	€72M
UK	€35M
Israel	€12M
France	€6.8M
Spain	€4.7M
Russia	€1.5M
Estonia	€1.4M
Poland	€770k

Stage mix

by € raised

Data table

	Healthtech — stage mix, Q4 2012
Series D+	€46M
Series C	€41M
Series A	€14M
Early VC	€12M
Grant	€7.4M
Series B	€6.6M
Seed	€4.3M
Other	€1.4M

Exits & M&A

1 Buyout

1 exit.

Top deals

largest disclosed rounds in Q4 2012

Company	Stage	Date	Amount
Biocartis	Series D+	Dec 2012	€35M
Endosense	Series C	Nov 2012	€31M
NeRRe Therapeutics	Series A	Dec 2012	€14M
EarlySense	Series D+	Nov 2012	€12M
GlySure	Series C	Nov 2012	€10M
Biom'Up	Early VC	Oct 2012	€6.8M
NovImmune	Grant	Oct 2012	€6.0M
Cardiosonic	Series B	Dec 2012	€4.7M
Qinec	Series B	Nov 2012	€1.9M
OR Productivity	Early VC	Dec 2012	€1.5M
BiOxyDyn	Early VC	Oct 2012	€1.5M
Calcivis	Early VC	Nov 2012	€1.5M
SelfDiagnostics	Grant	Nov 2012	€1.4M
Morria Biopharmaceuticals	Other	Dec 2012	€1.4M
Blackford Analysis	Seed	Nov 2012	€1.0M

View all 25 Healthtech deals in Q4 2012 →

Top investors

most active in Q4 2012, by deal count

← All 2012 Healthtech funding